Such data indicates the presence of the melatonergic pathway in tumor-like cells and the significant impact that alterations in this pathway can have, via mitochondrial CYP1B1 driving an increase in the mitochondrial NAS/melatonin ratio in tumor cells [127]. Here, CYP1B1 is linked to neoplasm.